Category: BioTech

BioTech

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares declined 1.14% to $8.65. The company on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -2.87% in last session and finished the day at $8.13. Traded volume was 13.50million shares in the last session and the average volume … Continue reading Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Jason Knox
BioTech

Is InterMune (NASDAQ:ITMN) a Takeover Candidate?

InterMune (NASDAQ:ITMN) March 34 and 35 calls are active on total call volume 3,100 contracts (500 puts) on attracting takeover interest, Reuters says. March call option implied volatility is at 90, April is at 88, May and July is at 82; compared to its 26-week average of 90 according to Track Data. Active call volume suggests traders taking positions for price movement, according to theflyonthewall.com. … Continue reading Is InterMune (NASDAQ:ITMN) a Takeover Candidate?

Ryan Holtz
BioTech

Biotech Losers: Novavax (NASDAQ:NVAX), Achillion Pharmaceuticals (NASDAQ:ACHN), The Clorox (NYSE:CLX), Halozyme Therapeutics (NASDAQ:HALO)

Novavax, Inc. (NASDAQ:NVAX) is a vaccine company that is likely to have multiple milestones this year. It has U.S. government funding for seasonal and pandemic flu, and is developing its own products for respiratory syncytial virus (RSV). Novavax, Inc. (NASDAQ:NVAX) stock performance was -5.02% in last session and finished the day at $6.05. Traded volume was 4.36million shares in the last session and the average … Continue reading Biotech Losers: Novavax (NASDAQ:NVAX), Achillion Pharmaceuticals (NASDAQ:ACHN), The Clorox (NYSE:CLX), Halozyme Therapeutics (NASDAQ:HALO)

Mark Doerr
BioTech

NASDAQ Active Runners: Sirius XM Holdings (NASDAQ:SIRI), Zynga Inc (NASDAQ:ZNGA), Micron Technology (NASDAQ:MU), Peregrine Pharmaceuticals (NASDAQ:PPHM)

SiriusXM XM Holdings Inc (NASDAQ:SIRI) announced that it will air a special broadcast of “El Show de Piolin” on Saturday, March 8 during the upcoming blockbuster Pay-Per-View boxing event, “TOE TO TOE: Canelo vs. Angulo,” featuring Mexican boxing superstar “Canelo” Alvarez facing veteran fellow countryman Alfredo “El Perro” Angulo. Sirius XM Holdings Inc (NASDAQ:SIRI) stock performance was 0.14% in last session and finished the day … Continue reading NASDAQ Active Runners: Sirius XM Holdings (NASDAQ:SIRI), Zynga Inc (NASDAQ:ZNGA), Micron Technology (NASDAQ:MU), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Jayne Crisman
BioTech

Biotech Active Stocks: MannKind Corporation (NASDAQ:MNKD), Inovio Pharmaceuticals (NYSEMKT:INO), Rexahn Pharmaceuticals (NYSEMKT:RNN), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) raises $63 million, secures capital needs for near-term trial advancement and preparation to enter Phase lll studies. Inovio Pharmaceuticals Inc (NYSEMKT:INO) dropped -1.96 percent to $3.51 yesterday on volume of INO 6.88million shares. The intra-day range of the stock was $3.50 to $3.71. Inovio Pharmaceuticals Inc (NYSEMKT:INO) has a market capitalization of $795.32million. After announcing two years ago that it would … Continue reading Biotech Active Stocks: MannKind Corporation (NASDAQ:MNKD), Inovio Pharmaceuticals (NYSEMKT:INO), Rexahn Pharmaceuticals (NYSEMKT:RNN), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Richard Atkins
BioTech

Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Officials with Zogenix Inc. (NASDAQ:ZGNX), the San Diego-based maker of Zohydro, did not return a message seeking comment about the drug. The company is marketing the drug as the first extended-release hydrocodone pain reliever without acetaminophen, which can cause liver failure if taken in excess. Zogenix, Inc. (NASDAQ:ZGNX) stock performance was -14.18% in last session and finished the day at $3.84. Traded volume was 9.38million … Continue reading Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Kristen Barton